AR019981A1 - Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. - Google Patents
Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida.Info
- Publication number
- AR019981A1 AR019981A1 ARP990103817A ARP990103817A AR019981A1 AR 019981 A1 AR019981 A1 AR 019981A1 AR P990103817 A ARP990103817 A AR P990103817A AR P990103817 A ARP990103817 A AR P990103817A AR 019981 A1 AR019981 A1 AR 019981A1
- Authority
- AR
- Argentina
- Prior art keywords
- solid
- pharmaceutical composition
- prepare
- procedure
- dosage form
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002459 sustained effect Effects 0.000 title abstract 2
- 239000007909 solid dosage form Substances 0.000 title 1
- 229920001285 xanthan gum Polymers 0.000 abstract 3
- 229940082509 xanthan gum Drugs 0.000 abstract 3
- 235000010493 xanthan gum Nutrition 0.000 abstract 3
- 239000000230 xanthan gum Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 230000005540 biological transmission Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002831 pharmacologic agent Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816723.2A GB9816723D0 (en) | 1998-08-01 | 1998-08-01 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019981A1 true AR019981A1 (es) | 2002-03-27 |
Family
ID=10836508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990103817A AR019981A1 (es) | 1998-08-01 | 1999-07-30 | Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1100471B1 (https=) |
| JP (1) | JP2002522376A (https=) |
| CN (1) | CN1160060C (https=) |
| AR (1) | AR019981A1 (https=) |
| AT (1) | ATE249815T1 (https=) |
| AU (1) | AU744483B2 (https=) |
| CA (1) | CA2339190C (https=) |
| DE (1) | DE69911427T2 (https=) |
| DK (1) | DK1100471T3 (https=) |
| ES (1) | ES2207274T3 (https=) |
| GB (1) | GB9816723D0 (https=) |
| MX (1) | MXPA01000992A (https=) |
| NZ (1) | NZ509593A (https=) |
| PT (1) | PT1100471E (https=) |
| WO (1) | WO2000007569A1 (https=) |
| ZA (1) | ZA200100828B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1610551A (zh) | 2001-07-06 | 2005-04-27 | 恩德制药公司 | 用作止痛剂的6－羟基羟吗啡酮的肠胃外给药 |
| AU2002337686B2 (en) * | 2001-09-26 | 2008-05-15 | Penwest Pharmaceuticals Company | Opioid formulations having reduced potential for abuse |
| CN117752805B (zh) * | 2023-12-25 | 2024-12-24 | 山东聊城阿华制药股份有限公司 | 一种药用辅料及其制备方法 |
| KR102881485B1 (ko) * | 2024-03-22 | 2025-11-05 | (주) 팜젠사이언스 | 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4135979A (en) * | 1976-08-24 | 1979-01-23 | Merck & Co., Inc. | Treatment of xanthan gum to improve clarity |
| GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
| US4915948A (en) * | 1987-08-31 | 1990-04-10 | Warner-Lambert Company | Tablets having improved bioadhesion to mucous membranes |
| CA2017249C (en) * | 1989-05-24 | 2000-07-25 | Theresa M. Ortega | Rheology controlled fabric printing composition and method |
-
1998
- 1998-08-01 GB GBGB9816723.2A patent/GB9816723D0/en not_active Ceased
-
1999
- 1999-07-28 AT AT99941487T patent/ATE249815T1/de not_active IP Right Cessation
- 1999-07-28 AU AU55087/99A patent/AU744483B2/en not_active Ceased
- 1999-07-28 CN CNB998113735A patent/CN1160060C/zh not_active Expired - Fee Related
- 1999-07-28 WO PCT/EP1999/005499 patent/WO2000007569A1/en not_active Ceased
- 1999-07-28 NZ NZ509593A patent/NZ509593A/xx unknown
- 1999-07-28 DE DE69911427T patent/DE69911427T2/de not_active Expired - Fee Related
- 1999-07-28 JP JP2000563255A patent/JP2002522376A/ja active Pending
- 1999-07-28 EP EP99941487A patent/EP1100471B1/en not_active Expired - Lifetime
- 1999-07-28 MX MXPA01000992A patent/MXPA01000992A/es unknown
- 1999-07-28 PT PT99941487T patent/PT1100471E/pt unknown
- 1999-07-28 DK DK99941487T patent/DK1100471T3/da active
- 1999-07-28 ES ES99941487T patent/ES2207274T3/es not_active Expired - Lifetime
- 1999-07-28 CA CA002339190A patent/CA2339190C/en not_active Expired - Fee Related
- 1999-07-30 AR ARP990103817A patent/AR019981A1/es unknown
-
2001
- 2001-01-30 ZA ZA200100828A patent/ZA200100828B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1100471T3 (da) | 2004-01-12 |
| CN1160060C (zh) | 2004-08-04 |
| CA2339190C (en) | 2008-11-18 |
| CN1354653A (zh) | 2002-06-19 |
| ES2207274T3 (es) | 2004-05-16 |
| ATE249815T1 (de) | 2003-10-15 |
| DE69911427T2 (de) | 2004-07-01 |
| DE69911427D1 (de) | 2003-10-23 |
| EP1100471A1 (en) | 2001-05-23 |
| EP1100471B1 (en) | 2003-09-17 |
| ZA200100828B (en) | 2001-10-22 |
| MXPA01000992A (es) | 2002-06-04 |
| AU5508799A (en) | 2000-02-28 |
| JP2002522376A (ja) | 2002-07-23 |
| NZ509593A (en) | 2002-12-20 |
| CA2339190A1 (en) | 2000-02-17 |
| AU744483B2 (en) | 2002-02-28 |
| PT1100471E (pt) | 2003-12-31 |
| GB9816723D0 (en) | 1998-09-30 |
| WO2000007569A1 (en) | 2000-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR059324A2 (es) | Una forma solida de dosificacion oral | |
| AR036700A1 (es) | Forma de dosificacion oral solida de simeticona | |
| AR042937A2 (es) | Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento | |
| ES2181055T3 (es) | Formulaciones galenicas que contienen antagonistas de opiaceos. | |
| BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
| AR022008A1 (es) | Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento | |
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| AR040722A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
| MXPA05007643A (es) | Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo. | |
| PE20060075A1 (es) | Composiciones farmaceuticas de alisciren | |
| HUP0000141A2 (hu) | Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására | |
| BRPI0410116A (pt) | tablete de cuidado oral | |
| AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
| ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
| CO4940406A1 (es) | Composiciones de paracetamol de accion rapida | |
| AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
| BR0214497A (pt) | Composição farmacêutica que compreende um agonista do receptor 5ht1 | |
| DE60221227D1 (de) | Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen | |
| AR045719A1 (es) | Formulacion farmaceutica que comprende levotiroxina sodica, celulosa microcristalina y almidon pregelatinizado; uso de la misma para la fabricacion de un medicamento y proceso para preparar dicha formulacion | |
| AR019981A1 (es) | Una composicion farmaceutica de liberacion sostenida solida, y un procedimiento para preparar una forma de dosificacion solida. | |
| ES2182526T3 (es) | Metodo para mejorar las propiedades ingenieriles del suelo. | |
| CL2004001843A1 (es) | Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax | |
| AR036755A1 (es) | Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel | |
| ES2197781A1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. | |
| AR032614A1 (es) | Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |